JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detwiler, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detwiler, P. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 180, Issue 2, 244-254, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF GERMINE-3-ACETATE ON NEUROMUSCULAR TRANSMISSION

Peter B. Detwiler 1

1 Department of Pharmacology, Georgetown University, Schools of Medicine and Dentistry, Washington, D. C.

Germine-3-acetate (GMA) is a veratrum derivative that causes repetitive nerve and muscle activity, increases skeletal muscle contraction strength, antagonizes neuromuscular block by d-tubocurarine and succinylcholine and has been reported to be effective in the treatment of myasthenia gravis. The effects of GMA on neuromuscular transmission were studied in the in vitro frog sartorius nerve muscle preparation. GMA has no effect on unstimulated preparations but causes the response evoked by a single nerve or muscle stimulus to become repetitive. Concentrations of GMA which cause repetitive nerve and muscle activity (1-20 µg/ml) do not change miniature end-plate potential amplitude or frequency in either normal or high Mg++-low Ca++ Ringer's solution. These concentrations of GMA do not change the amplitude, quantum size, quatum content, time course or primary potentiation of end-plate potentials recorded from preparations in which neuromuscular transmission is depressed by high Mg++-low Ca++ Ringer's solution. Accordingly, the production of repetitive nerve activity by GMA is not a consequence of increased transmitter release or of intensification or prolongation of transmitter action. GMA apparently represents a new type of neuromuscular reagent in that it profoundly affects neuromuscular function but does not influence neuromuscular transmission, i.e., GMA does not alter the processes involved in transmitter release, action or removal.

Submitted on June 28, 1971
Accepted on October 11, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.